Related Experiment Videos

Advanced drug therapy in juvenile rheumatoid arthritis

C A Gabriel¹, J E Levinson

¹Children's Hospital Medical Center, Special Treatment Center for Juvenile Arthritis, Cincinnati, Ohio 45229-2899.

Arthritis and Rheumatism

|April 1, 1990

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Use of total abdominal hysterectomy and hormone replacement therapy in BRCA1 and BRCA2 mutation carriers undergoing risk-reducing salpingo-oophorectomy.

Familial cancer·2008

What more can we learn from muscle histopathology in children with dermatomyositis/polymyositis?

Clinical and experimental rheumatology·2006

Development of validated disease activity and damage indices for the juvenile idiopathic inflammatory myopathies. II. The Childhood Myositis Assessment Scale (CMAS): a quantitative tool for the evaluation of muscle function. The Juvenile Dermatomyositis Disease Activity Collaborative Study Group.

Arthritis and rheumatism·1999

Long-term health outcomes and quality of life in American and Italian inception cohorts of patients with juvenile rheumatoid arthritis. I. Outcome status.

The Journal of rheumatology·1997

Long-term health outcomes and quality of life in American and Italian inception cohorts of patients with juvenile rheumatoid arthritis. II. Early predictors of outcome.

The Journal of rheumatology·1997

Antibodies to the 45 kDa DEK nuclear antigen in pauciarticular onset juvenile rheumatoid arthritis and iridocyclitis: selective association with MHC gene.

The Journal of rheumatology·1997

See all related articles